10-Q | 2020-09-30 | Filed 2020-11-03 |
10-Q | 2020-06-30 | Filed 2020-08-04 |
10-Q | 2020-03-31 | Filed 2020-05-15 |
10-K | 2019-12-31 | Filed 2020-02-26 |
10-Q | 2019-09-30 | Filed 2019-10-30 |
10-Q | 2019-06-30 | Filed 2019-08-02 |
10-Q | 2019-03-31 | Filed 2019-04-30 |
10-K | 2018-12-31 | Filed 2019-02-27 |
10-Q | 2018-09-30 | Filed 2018-10-29 |
10-Q | 2018-06-30 | Filed 2018-08-03 |
S-1 | 2018-04-30 | Public Filing |
10-Q | 2018-03-31 | Filed 2018-04-27 |
10-K | 2017-12-31 | Filed 2018-02-16 |
10-Q | 2017-09-30 | Filed 2017-10-27 |
10-Q | 2017-06-30 | Filed 2017-08-04 |
8-K | 2020-11-02 | |
8-K | 2020-08-03 | |
8-K | 2020-06-29 | |
8-K | 2020-06-16 | |
8-K | 2020-06-16 | |
8-K | 2020-06-16 | |
8-K | 2020-06-12 | |
8-K | 2020-06-05 | |
8-K | 2020-06-05 | |
8-K | 2020-05-12 | |
8-K | 2020-05-01 | |
8-K | 2020-04-15 | |
8-K | 2020-02-28 | |
8-K | 2020-02-21 | |
8-K | 2020-02-17 | |
8-K | 2020-02-13 | |
8-K | 2020-01-30 | |
8-K | 2020-01-27 | |
8-K | 2019-12-12 | |
8-K | 2019-10-28 | |
8-K | 2019-10-03 | |
8-K | 2019-07-31 | |
8-K | 2019-06-29 | |
8-K | 2019-06-28 | |
8-K | 2019-05-09 | |
8-K | 2019-04-30 | |
8-K | 2019-04-30 | |
8-K | 2019-04-30 | |
8-K | 2019-02-19 | |
8-K | 2018-12-18 | |
8-K | 2018-12-13 | |
8-K | 2018-11-28 | |
8-K | 2018-10-31 | |
8-K | 2018-10-25 | |
8-K | 2018-10-24 | |
8-K | 2018-09-11 | |
8-K | 2018-08-01 | |
8-K | 2018-05-10 | |
8-K | 2018-05-02 | |
8-K | 2018-04-26 | |
8-K | 2018-02-15 | |
8-K | 2018-02-07 | |
8-K | 2018-01-05 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 246 | 303 | 393 | 354 | 338 | 269 | 221 | 264 | 318 | 406 |
Accounts Receivable | 475 | 532 | 536 | 542 | 496 | 525 | 525 | 510 | 499 | 458 |
Inventory | 486 | 508 | 494 | 567 | 556 | 550 | 524 | 555 | 558 | 539 |
PP&E | 356 | 352 | 567 | 365 | 354 | 347 | 607 | 350 | 345 | 334 |
Assets | 4,423 | 4,553 | 4,621 | 4,775 | 4,605 | 4,516 | 4,487 | 4,567 | 4,594 | 4,554 |
Accounts Payable | 246 | 264 | 270 | 285 | 311 | 320 | 340 | 342 | 332 | 337 |
Long-Term Debt | 1,982 | 2,028 | 2,040 | 2,055 | 1,911 | 1,755 | 1,672 | 1,630 | 1,632 | 1,602 |
Liabilities | 3,214 | 3,281 | 3,144 | 3,208 | 3,036 | 2,893 | 2,811 | 2,829 | 2,809 | 2,763 |
Stockholders' Equity | 1,209 | 1,272 | 1,477 | |||||||
Income Statement ($MM) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 579 | 650 | 665 | 620 | 668 | 689 | 620 | 629 | 597 | |
Cost of Revenue | 363 | 396 | 412 | 388 | 419 | 427 | 390 | 395 | 375 | |
Gross Profit | 216 | 254 | 254 | 232 | 249 | 262 | 230 | 234 | 222 | |
R&D | ||||||||||
SG&A | 126 | 111 | 108 | 107 | 116 | 108 | 108 | 104 | 95 | |
Tax | -44 | 16 | 8 | 23 | 49 | 23 | 14 | 8 | 9 | |
Net Income | -146 | 28 | 144 | 42 | 60 | 72 | 47 | 45 | 41 | |
Cash Flow ($MM) | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 64 | 117 | 60 | 134 | 104 | 69 | 61 | 114 | ||
Cash Investing | -2 | -18 | -102 | -29 | -11 | -15 | -10 | -21 | ||
Cash Financing | -9 | -9 | -8 | -106 | -158 | -17 | 1 | 3 |